I agree that this site is using cookies. You can find further informations here.
X
Anagnostou, Nicholas
78  results:
Search for persons X
?
1

Carbapenemase‐producing Enterobacterales: a profound threat..:

Flynn, Erin ; Papanicolas, Lito E ; Anagnostou, Nicholas..
Medical Journal of Australia.  219 (2023)  7 - p. 290-292 , 2023
Link: https://doi.org/10.5694/..
 
?
2

OC 8552 EFFICACY OF THE CHAD63-MVC ME-TRAP VECTORED MALARIA..:

Tiono, Alfred B ; Nebie, Issa ; Anagnostou, Nicholas...
BMJ Global Health.  4 (2019)  Suppl 3 - p. A13.1-A13 , 2019
Link: https://doi.org/10.1136/..
 
?
3

Very early‐onset ofCryptococcus neoformansdisease following..:

Marinelli, Tina ; Anagnostou, Nicholas ; Daniel, Santhosh..
Transplant Infectious Disease.  22 (2019)  1 - p. , 2019
Link: https://doi.org/10.1111/..
 
?
4

First field efficacy trial of the ChAd63 MVA ME-TRAP vector..:

Tiono, Alfred B. ; Nébié, Issa ; Anagnostou, Nicholas...
PLOS ONE.  13 (2018)  12 - p. e0208328 , 2018
Link: https://doi.org/10.1371/..
 
?
5

Psoriasis and infection. A clinical practice narrative:

Rademaker, Marius ; Agnew, Karen ; Anagnostou, Nicholas...
Australasian Journal of Dermatology.  60 (2018)  2 - p. 91-98 , 2018
Link: https://doi.org/10.1111/..
 
?
6

Assessment of novel vaccination regimens using viral vector..:

Bliss, Carly M. ; Bowyer, Georgina ; Anagnostou, Nicholas A....
Scientific Reports.  8 (2018)  1 - p. , 2018
Link: https://doi.org/10.1038/..
 
?
7

Safety and immunogenicity of heterologous prime-boost immun..:

Venkatraman, Navin ; Anagnostou, Nicholas ; Bliss, Carly...
Vaccine.  35 (2017)  45 - p. 6208-6217 , 2017
Link: https://doi.org/10.1016/..
 
?
8

Viral Vector Malaria Vaccines Induce High-Level T Cell and ..:

Bliss, Carly M. ; Drammeh, Abdoulie ; Bowyer, Georgina...
Molecular Therapy.  25 (2017)  2 - p. 547-559 , 2017
Link: https://doi.org/10.1016/..
 
?
9

Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West..:

Afolabi, Muhammed O ; Tiono, Alfred B ; Adetifa, Uche J...
Molecular Therapy.  24 (2016)  8 - p. 1470-1477 , 2016
Link: https://doi.org/10.1038/..
 
?
10

Safety, Immunogenicity and Efficacy of Prime-Boost Vaccinat..:

Mensah, Victorine A. ; Gueye, Aly ; Ndiaye, Magatte...
PLOS ONE.  11 (2016)  12 - p. e0167951 , 2016
Link: https://doi.org/10.1371/..
 
?
11

Increased sample volume and use of quantitative reverse-tra..:

Hodgson, Susanne H ; Douglas, Alexander D ; Edwards, Nick J...
Malaria Journal.  14 (2015)  1 - p. , 2015
Link: https://doi.org/10.1186/..
 
?
12

Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines ..:

Hodgson, Susanne H. ; Ewer, Katie J. ; Bliss, Carly M....
The Journal of Infectious Diseases.  211 (2015)  7 - p. 1076-1086 , 2015
Link: http://www.jstor.org/sta..
 
?
13

Translating the Immunogenicity of Prime-boost Immunization ..:

Kimani, Domtila ; Jagne, Ya Jankey ; Cox, Momodou...
Molecular Therapy.  22 (2014)  11 - p. 1992-2003 , 2014
Link: https://doi.org/10.1038/..
 
?
14

Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines ..:

Hodgson, Susanne H. ; Ewer, Katie J. ; Bliss, Carly M....
Journal of Infectious Diseases.  211 (2014)  7 - p. 1076-1086 , 2014
Link: https://doi.org/10.1093/..
 
?
15

Safety and Immunogenicity of Heterologous Prime-Boost Immun..:

Ogwang, Caroline ; Afolabi, Muhammed ; Kimani, Domtila...
PLoS ONE.  8 (2013)  3 - p. e57726 , 2013
Link: https://doi.org/10.1371/..
 
1-15